Table 3 Demographic and clinical features in divided groups based upon the clinical presentation.
From: Clinical presentation of abdominal tuberculosis in HIV seronegative adults
Groups* | I (n = 24) | II (n = 24) | III (n = 22) | IV (n = 9) | V (n = 9) | P |
|---|---|---|---|---|---|---|
Age (yr) | 36.5 ± 20 | 30.4 ± 13 | 23.5 ± 8 | 32.7 ± 12 | 38 ± 16 | 0.048 |
Gender (F/M) | 12/12 | 13/11 | 14/8 | 2/7 | 5/4 | 0.34 |
Disease Duration (mo) | 11.3 ± 23 | 6 ± 8 | 9.8 ± 14 | 25 ± 41 | 6.6 ± 5 | 0.869 |
Previous history of TB % | 16.7 | 8.3 | 18.2 | 22.2 | 33.3 | 0.530 |
Family history for TB % | 8.3 | 4.2 | 18.2 | 11.1 | 0 | 0.425 |
Weight loss (kg) | 8.2 ± 7 | 6 ± 4.5 | 8.5 ± 6 | 8.7 ± 5 | 8.1 ± 7.2 | 0.496 |
Temperature (°C) | 37.5 ± 1 | 37.4 ± 0.8 | 37.5 ± 1 | 37.9 ± 0.9 | 37.2 ± 1 | 0.615 |
Fistula (%)* | 8.3 | 0 | 31.8 | 0 | 22.2 | 0.07 |
Therapeutic Operation % | 33.3 | 12.5 | 27.3 | 66.6 | 22.2 | 0.001 |
Response to therapy % | 91.7 | 95.8 | 90.9 | 77.7 | 100 | 0.354 |
First response to therapy (mo) | 2.5 ± 1.5 | 2.1 ± 1.6 | 1.9 ± 1.3 | 2.6 ± 1.5 | 2.8 ± 2 | 0.298 |
Death % | 8.3 | 4.2 | 4.5 | 11.1 | 0 | 0.825 |